Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-01, Stock:ABBV, The news for the past five days is as follows:
2019-07-25: NEWS1: Pre-Market Earnings Report for July 26, 2019 :  MCD, ABBV, CHTR, CL, ITW, AON, PSX, TWTR, ZBH, VTR, WY, YNDX.NEWS2: Pre-Market Earnings Report for July 26, 2019 :  MCD, ABBV, CHTR, CL, ITW, AON, PSX, TWTR, ZBH, VTR, WY, YNDX.NEWS3: Should You Buy AbbVie (ABBV) Ahead of Earnings?.NEWS4: Should You Buy AbbVie (ABBV) Ahead of Earnings?.NEWS5: Zacks.com featured highlights include: Amedisys, AbbVie, Laureate, Genesco and Valeritas.NEWS6: Zacks.com featured highlights include: Amedisys, AbbVie, Laureate, Genesco and Valeritas.NEWS7: Roche (RHHBY) 1H19 Earnings & Sales Up Y/Y, View Raised.NEWS8: Roche (RHHBY) 1H19 Earnings & Sales Up Y/Y, View Raised.
2019-07-26: NEWS1: AbbVie Inc (ABBV) Q2 2019 Earnings Call Transcript.NEWS2: AbbVie Earnings: ABBV Stock Pops on Q2 Beat.NEWS3: AbbVie Earnings: ABBV Stock Pops on Q2 Beat.NEWS4: 5 Things You Need to Know From AbbVie's Q2 Earnings Results.NEWS5: 5 Things You Need to Know From AbbVie's Q2 Earnings Results.NEWS6: 5 Things You Need to Know From AbbVie&apos;s Q2 Earnings Results.NEWS7: AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View.NEWS8: AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View.NEWS9: Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 5%.NEWS10: Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 5%.NEWS11: AbbVie Earnings: ABBV Stock Pops on Q2 Beat.NEWS12: AbbVie Discontinued a Drug Trial. Biogen Stock Is Falling..NEWS13: AbbVie (ABBV) Beats on Q2 Earnings & Sales, Raises EPS View.NEWS14: AbbVie spotlights Allergan deal, new drugs as Humira sales wane.NEWS15: AstraZeneca (AZN) Jumps: Stock Rises 5.7%.NEWS16: AstraZeneca (AZN) Jumps: Stock Rises 5.7%.NEWS17: AbbVie (ABBV) Tops Q2 Earnings and Revenue Estimates.NEWS18: AbbVie (ABBV) Tops Q2 Earnings and Revenue Estimates.NEWS19: AbbVie Reverses 4-Day Dive — But Its Biggest Moneymaker Is In Trouble.NEWS20: Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 5%.NEWS21: AbbVie (ABBV) Beats Q2 Earnings and Revenues, Shares Up.NEWS22: AbbVie (ABBV) Beats Q2 Earnings and Revenues, Shares Up.NEWS23: AbbVie does not expect to divest new psoriasis drug.NEWS24: AbbVie stock up 2% after earnings beat.NEWS25: AbbVie (ABBV) Tops Q2 Earnings and Revenue Estimates.NEWS26: UPDATE 2-AbbVie spotlights Allergan deal, new drugs as Humira sales wane.NEWS27: AstraZeneca (AZN) Jumps: Stock Rises 5.7%.NEWS28: AbbVie Delivers a Win on Earnings and Raises Profit Forecast.NEWS29: AbbVie raises guidance as cancer treatments boost sales.NEWS30: AbbVie (ABBV) Beats Q2 Earnings and Revenues, Shares Up.NEWS31: AbbVie raises 2019 profit target as quarterly sales beat estimates.NEWS32: AbbVie Reports Second-Quarter 2019 Financial Results.NEWS33: McDonald's, AbbVie, and Twitter - Earnings to Watch.NEWS34: AbbVie Rises 3%.NEWS35: [video]AbbVie Rises on Strong Second-Quarter Results, Raised Guidance.NEWS36: AbbVie Earnings, Revenue Beat in Q2.NEWS37: Buy Merck & Co (MRK) Stock Ahead of Q2 Earnings Report?.NEWS38: Buy Merck & Co (MRK) Stock Ahead of Q2 Earnings Report?.
2019-07-29: NEWS1: Edited Transcript of ABBV earnings conference call or presentation 26-Jul-19 1:00pm GMT.NEWS2: Noteworthy Monday Option Activity: SYNA, ABBV, VGR.NEWS3: Noteworthy Monday Option Activity: SYNA, ABBV, VGR.NEWS4: Pfizer to Combine Off-Patent Drug Business With Mylan.
2019-07-30: NEWS1: Why Neurocrine Biosciences Stock Is Jumping Today.NEWS2: Why Neurocrine Biosciences Stock Is Jumping Today.NEWS3: Merck Shares Rise on Strong Sales Growth.NEWS4: Why Neurocrine Biosciences Stock Is Jumping Today.NEWS5: Cramer Weighs In On AbbVie, Six Flags And More.NEWS6: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS7: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS8: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS9: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS10: Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y.NEWS11: Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y.NEWS12: The 5 Worst S&P 500 Stocks Are Costing You $22.3 Billion; Here's Why.NEWS13: Neurocrine Biosciences Posts Sizzling Sales Growth in Q2.NEWS14: Neurocrine Biosciences Posts Sizzling Sales Growth in Q2.
2019-07-31: NEWS1: Abbvie Inc (ABBV) EVP, Chief Strategy Officer Henry O Gosebruch Bought $2 million of Shares.NEWS2: AbbVie (NYSE:ABBV) Shareholders Have Enjoyed A 29% Share Price Gain.

Answer: Decrease